meta_analysis
    2024

    Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis

    Li Y, Wang Y, Zhang X, Chen L

    Published in Renal Failure

    Key Findings

    Astragalus added to RAAS blockade reduced urinary albumin excretion, serum creatinine and blood urea nitrogen compared with RAAS blockade alone.

    Conclusions

    Adjunctive astragalus may improve renal markers in stage III diabetic nephropathy.

    Limitations

    Almost all trials conducted in China with high risk of bias; short follow-up; surrogate endpoints.

    Supplements Studied

    Astragalus added to RAAS blockade reduced urinary albumin excretion, serum creatinine and blood urea nitrogen.

    Related Health Concerns

    Type 2 Diabetes
    Chronic Kidney Disease

    Study Details

    Year:2024
    Sample Size:2,000
    Duration:12 weeks
    Quality Score:6/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.